Merck is trading at $149.05 (+3.03%), with its move appearing consistent with a broader healthcare-sector rally following the Democratic sweep in the midterm elections.
- Reports noted pharmaceutical stocks, including Merck, were higher, though policy benefits for drugmakers are indirect.
- No clear company-specific announcement explained the November 4 rise; Merck’s third-quarter results and raised guidance were reported October 29 and are prior context, not a new catalyst.